Dawnrays Pharmaceutical (Holdings) Limited

Medicines, APIs, Intermediates

Products
  • No Categories
Search Minisite
 
Links
  • No Links
Current Position:Home » Welcome
Introduction
Dawnrays Pharma was founded in December 1995, it is principally engaged in the development, manufacture and sales of cephalosporin antibiotics and system specific medicines. Dawnrays Pharmaceutical (Holdings) Limited was listed on the main board of The Hong Kong Stock Exchange on July 11, 2003 with stock code 02348.HK.


Dawnrays Pharma owns eight subsidiaries, namely Dawnrays International Company Limited, Dawnrays International Co., Ltd., Dawnrays Biotechnology Capital (Asia) Ltd., Suzhou Dawnrays Pharmaceutical Co., Ltd., Suzhou Dawnrays Pharmaceutical Science and Technology Co., Ltd., Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd., Guangdong Dawnrays Pharmaceutical Co., Ltd. and Dawnrays Pharma (Hong Kong) Limited. As a Hong Kong listed company, the Group’s overall decision-making and management strictly conform to Hong Kong corporate governance requirements, its business positioning is fixed on a global perspective while holding angles on the entire glo... [MORE]